Updates: Company News; Industry trends

Industry trends

Arrowhead joins the battlefield with a new RNAi approval.

Learn more

2025-11-19 12:04:04

11 / 19

2025
From 0 to 1! Fosun Pharma's POHERDY® is approved by the FDA to become the first biosimilar of pertuzumab in the United States.

Learn more

2025-11-18 12:04:04

11 / 18

2025
In vivo CAR-T: EDV+AAV dual vectors - precise insertion of CAR at specific sites.

Learn more

2025-11-15 12:04:03

11 / 15

2025
A Phase II trial of the PD-1×CTLA-4 bispecific antibody has failed.

Learn more

2025-11-14 13:03:09

11 / 14

2025
After the failure of the Phase III clinical trial the shareholders plan to buy the company.

Learn more

2025-11-13 17:02:04

11 / 13

2025
Sdance: Solid Tumor CAR-T Going Global!

Learn more

2025-11-11 16:04:04

11 / 11

2025
Sana halts the development of allogeneic CAR-T.

Learn more

2025-11-10 12:17:03

11 / 10

2025
Intellia's in vivo CRISPR: A patient died after experiencing grade 4 hepatotoxicity.

Learn more

2025-11-07 12:20:03

11 / 07

2025

SHEN ZHEN ANGELO All Rights Reserved

Guangdong ICP No. 2023111766